Expert opinion on available options treating pulmonary arterial hypertension.

@article{Naeije2007ExpertOO,
  title={Expert opinion on available options treating pulmonary arterial hypertension.},
  author={Robert Naeije and Sandrine Huez},
  journal={Expert opinion on pharmacotherapy},
  year={2007},
  volume={8 14},
  pages={2247-65}
}
Until in the early nineties, pulmonary arterial hypertension (PAH) was a uniformly fatal disease, with a median life expectancy of approximately 2.5 years. Uncontrolled studies showed that a small proportion of patients responded to high-dose calcium channel blockers, retrospective studies supported the use of anticoagulant therapy and heart-lung or lung transplantation remained the only option. In 1996, a 3-month randomised, placebo-controlled trial showed that chronic intravenous epoprostenol… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 19 extracted citations

Similar Papers

Loading similar papers…